Haleon Seeking: Oral Microbiome Modulation for Improved Gum Health

シェア

Description 

We are looking for new ingredients, raw materials, and technologies that can be incorporated into conventional oral care products, including toothpaste and ideally mouthwash, to beneficially modulate the oral microbiome and help prevent or reverse dysbiosis associated with gingivitis.

Background

Recent advances in sequencing technologies, systems biology, and computational modeling have significantly improved understanding of the oral microbiome. Under healthy conditions, the oral microbiome exists in a benign and balanced relationship with host tissues. However, shifts in this microbial community (dysbiosis) are a key aetiological factor underpinning gingivitis. If left unresolved, gingivitis can progress to periodontitis, and result in tooth loss; furthermore, periodontitis has been associated with systemic conditions including diabetes, cardiovascular disease, and cerebrovascular disease.

 

Clearer differentiation between health-associated and disease-associated microbial communities is now possible, and research is beginning to elucidate the pathways that govern microbial balance and stability. While interest in microbiome modulation through everyday consumer products is increasing, most oral care approaches remain focused on broad-spectrum antimicrobial activity rather than selectively supporting beneficial microbial communities. This gap creates an opportunity to develop targeted strategies with the potential to guide the oral microbiome toward a healthier and more resilient state.

 

Ingredients incorporated into everyday oral care products that can modulate microbiome balance may offer the potential to protect against transitions from healthy microbiome to dysbiosis, thereby reducing the development of gingivitis; treat early-stage dysbiosis and gingival inflammation to restore a healthy state; and build resilience by promoting a microbiome composition that is more resistant to future dysbiotic shifts.


Key Success Criteria

Must-have requirements:

  • Data proving efficacy in vitro or in vivo performance of the actives/technologies/formats
  • Preliminary stability data or a scientifically justified rationale supporting expected stability under relevant storage conditions
  • Safe and suitable for daily oral use, with safety and toxicity information provided, or a plan to generate it
  • Cost-effective for inclusion in a daily-use consumer product (provide indicative cost/kg)
  • Regulatory pathway identified, including applicable frameworks (e.g., cosmetic, OTC, MDR), with indication of GRAS status or equivalent where relevant

 

Nice-to-have:

  • Suitable for formulation into oral care formats
  • Compatible with conventional oral care product excipients and actives including fluoride, surfactants, flavors
  • Acceptable taste and sensory attributes, with any negative aspects clearly identified
  • Commercially available or expected to reach commercialization within 3-5 years
  • Defined or hypothesized mechanism of action

 

Possible Approaches

  • Ingredients that will beneficially modulate the microbiome to prevent or reverse dysbiotic shifts associated with gingivitis
  • Ingredients which would modify the environment in the oral cavity or in specific parts of the oral cavity to favor health
  • Prebiotics: ingredients comprising nutrients for beneficial oral microbes
  • Postbiotics: ingredients comprising inactivated (typically pasteurized/heat killed) microorganisms and/or their products/metabolites
  • Targeted delivery systems for oral microbiome modulation
  • Technologies enabling sustained or localized release in the oral cavity
  • Smart or responsive systems triggered by oral conditions (e.g., pH, inflammation)

 

Approaches Not of Interest

  • Solutions incorporating live microorganisms (probiotics)
  • Technologies containing zinc as an active component
  • Engineered nanomaterials subject to regulatory restrictions
  • Solutions that deliver supplementary benefits which can be classed as having medicinal action

 

Preferred Collaboration types

  • Academic researchers
  • Startups
  • Suppliers
  • Service Providers (CROs/CMOs)
  • Consultants

Additional Information

  • Acceptable technology readiness levels (TRL): 3–9

 

Submit your solutions here

 

 

Related Tech Needs:

Haleon Seeking: Novel Fixative Technologies for Superior Denture Hold and User Experience

 

Haleon Seeking: Innovative Solutions for Teeth Sensitivity and Acid Erosion

 

Haleon Seeking: Oral Health Behavioural Solutions – Encouraging Better Brushing Habits

 

 

Image generated by OpenAI 

 

シェア

スタート

当社の営業チームにご連絡いただければ、即効性を発揮し、長期的な戦略的価値を引き出すためのソリューションをお客様と一緒にお探しします。